Back to Search Start Over

Expression of Par3 polarity protein correlates with poor prognosis in ovarian cancer

Authors :
Haruka Nishida
Katsutoshi Oda
Mitsuyo Yoshida
Kei Kawana
Tomoyuki Fujii
Ayumi Taguchi
Yutaka Osuga
Hiroe Nakamura
Tomoko Inoue
Takeshi Nagamatsu
Masakazu Sato
Yuriko Uehara
Kazunori Nagasaka
Takahide Arimoto
Katsuyuki Adachi
Asaha Fujimoto
Source :
BMC Cancer
Publisher :
Springer Nature

Abstract

Background Previous studies have shown that the cell polarity protein partitioning defective 3 (Par3) plays an essential role in the formation of tight junctions and definition of apical-basal polarity. Aberrant function of this protein has been reported to be involved in epithelial–mesenchymal transition (EMT) and cancer invasion. The aim of this study was to examine the functional mechanism of Par3 in ovarian cancer. Methods First, we investigated the association between Par3 expression level and survival of 50 ovarian cancer patients. Next, we conducted an in vitro analysis of ovarian cancer cell lines, focusing on the cell line JHOC5, to investigate Par3 function. To investigate the function of Par3 in invasion, the IL-6/STAT3 pathway was analyzed upon Par3 knockdown with siRNA. The effect of siRNA treatment was assessed by qPCR, ELISA, and western blotting. Invasiveness and cell proliferation following treatment with siRNA against Par3 were investigated using Matrigel chamber, wound healing, and cell proliferation assays. Results Expression array data for ovarian cancer patient samples revealed low Par3 expression was significantly associated with good prognosis. Univariate analysis of clinicopathological factors revealed significant association between high Par3 levels and peritoneal dissemination at the time of diagnosis. Knockdown of Par3 in JHOC5 cells suppressed cell invasiveness, migration, and cell proliferation with deregulation of IL-6/STAT3 activity. Conclusion Taken together, these results suggest that Par3 expression is likely involved in ovarian cancer progression, especially in peritoneal metastasis. The underlying mechanism may be that Par3 modulates IL-6 /STAT3 signaling. Here, we propose that the expression of Par3 in ovarian cancer may control disease outcome. Electronic supplementary material The online version of this article (doi:10.1186/s12885-016-2929-2) contains supplementary material, which is available to authorized users.

Details

Language :
English
ISSN :
14712407
Volume :
16
Issue :
1
Database :
OpenAIRE
Journal :
BMC Cancer
Accession number :
edsair.doi.dedup.....639226c56850e317663b708e34685c6b
Full Text :
https://doi.org/10.1186/s12885-016-2929-2